Amneal Pharmaceuticals (NASDAQ:AMRX) Coverage Initiated by A

StockNews.com initiated coverage on shares of Amneal Pharmaceuticals (NASDAQ:AMRX – Free Report) in a report published on Wednesday. The firm issued a buy rating on the stock. Separately, Truist Financial upped their target price on Amneal Pharmaceuticals from $6.00 to $7.00 and gave the company a buy rating in a research report on Wednesday, November […]

Related Keywords

Ohio , United States , American , , Amneal Pharmaceuticals Stock Down , Nasdaq , American Century Companies Inc , Vanguard Group Inc , Amneal Pharmaceuticals Company Profile , Amneal Pharmaceuticals , Jacobs Levy Equity Management Inc , News Ratings For Amneal Pharmaceuticals Daily , Analyst Recommendations For Amneal Pharmaceuticals , Amneal Pharmaceuticals Inc , Free Report , Truist Financial , Moderate Buy , Pharmaceuticals Stock Down , Get Free Report , Employees Retirement System , Capital Management , Century Companies , Jacobs Levy Equity Management , Levy Equity Management , Amneal Pharmaceuticals Daily , Nasdaq Amrx , Amrx , Medical , Initiated Coverage , Stocknews Com ,